Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 50 to 74 years old at the time of joining the trial
- You have gone through menopause, meaning you have had no periods for 12 months or more
- You still have at least one ovary
- You are currently cancer-free and have not had chemotherapy or radiation treatment in the past 12 months or more
- You are willing to come back for an annual CA-125 blood test (a blood test that can help detect certain conditions)
- You are willing to have a transvaginal ultrasound (an internal scan) if the trial team asks you to
- You can provide the name of a gynaecologist or suitable healthcare professional who can give you follow-up care if needed
Who may not be able to join:
- You are younger than 50 or older than 75 years of age
- You have a psychiatric, psychological, or other condition that would prevent you from fully understanding and agreeing to take part
- You have had both ovaries removed
- You currently have an active cancer that is not ovarian cancer
- You have a history of cancer (other than ovarian) and have received treatment within the last 12 months — though exceptions may apply for certain skin cancers or if you are taking specific hormone-related medications (confirm with trial site)
- You are considered at high risk for ovarian cancer because of a strong family history, such as carrying a known BRCA1 or BRCA2 gene mutation, or having multiple close relatives with ovarian or breast cancer — full details of what counts as "high risk" should be confirmed with the trial site
- You have or are a known or suspected carrier of a hereditary condition called Lynch Syndrome (also known as HNPCC), which increases cancer risk (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Denise Nebgen, MD, PHD, M.D. Anderson Cancer Center
Phone: 713-563-1790
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of increase in CA 125 levels and other tumor markers over time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.